1-2 of 2
Irmela Jeremias
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

Juan Lázaro-Navarro, Helia Judith Pimentel-Gutiérrez, Anton Gauert, Anja I. H. Hagemann, Jassi Eisenschmid, Nicola Gökbuget, Binje Vick, Irmela Jeremias, Felix Seyfried, Lüder Hinrich Meyer, Klaus-Michael Debatin, Kathrin Richer, Miriam Bultman, Martin Neumann, Sonja Hänzelmann, Hubert Serve, Kathy Astrahantseff, Michael A. Rieger, Cornelia Eckert, Claudia D. Baldus, Lorenz Bastian
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5501–5506.
https://doi.org/10.1182/bloodadvances.2021004513
Published: 2021
Includes: Supplemental data
Journal Articles

Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL

Clinical Trials & Observations
Ina-Katrin Siekmann, Kevin Dierck, Sebastian Prall, Marianne Klokow, Julia Strauss, Sophia Buhs, Antonina Wrzeszcz, Michael Bockmayr, Florian Beck, Magdalena Trochimiuk, Kristina Gottschling, Victoria Martens, Melissa Khosh-Naucke, Helwe Gerull, Jürgen Müller, Lena Behrmann, Martin Blohm, René P. Zahedi, Irmela Jeremias, Albert Sickmann, Peter Nollau, Martin A. Horstmann
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2554–2567.
https://doi.org/10.1182/bloodadvances.2018020693
Published: 2018
Includes: Supplemental data